UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019137
Receipt No. R000022124
Official scientific title of the study Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients(JUST-STUDY)-additional research on patients enrolled in JUST-STUDY-
Date of disclosure of the study information 2015/09/28
Last modified on 2018/05/07 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients(JUST-STUDY)-additional research on patients enrolled in JUST-STUDY-
Title of the study (Brief title) Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients(JUST-STUDY)-additional research on patients enrolled in JUST-STUDY-
Region
Japan

Condition
Condition Breast cancer
Classification by specialty
Hematology and clinical oncology Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To do additional research on safety and efficacy of 88 patients enrolled in JUST-study, for further discussion of bi-weekly eribulin therapy
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Phase II

Assessment
Primary outcomes Time to Treatment Failure(TTF) of bi-weekly patients
Key secondary outcomes Overall survival(OS), safety

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria All who enrolled in JUST-STUDY
Key exclusion criteria none
Target sample size 88

Research contact person
Name of lead principal investigator Shoichiro Ohtani
Organization Hiroshima City Hospital
Division name Breast Surgery
Address 7-33, Motomachi, Naka-ku, Hiroshima-shi, Hiroshima-ken
TEL 082-22102291
Email eriburlin-study@npo-acro.jp

Public contact
Name of contact person JUST-STUDY Executive Office
Organization NPO Advanced Clinical Reserch Organization
Division name JUST-STUDY Executive Office
Address 2-10-3,kotobukicho,Fuchu,Tokyo
TEL 042-352-7676
Homepage URL
Email eriburlin-study@npo-acro.jp

Sponsor
Institute NPO Advanced Clinical Reserch Organization
Institute
Department

Funding Source
Organization NPO Advanced Clinical Reserch Organization
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 09 Month 28 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 07 Month 23 Day
Anticipated trial start date
2015 Year 09 Month 28 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information a

Management information
Registered date
2015 Year 09 Month 28 Day
Last modified on
2018 Year 05 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022124